Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 7, 2008, Pages 2681-2686

  Buxbaum, Joel N ^a   Ye, Zhengyi ^a   Reixach, Natàlia ^a   Friske, Linsey ^a   Levy, Coree ^a   Das, Pritam ^b   Golde, Todd ^b   Masliah, Eliezer ^c   Roberts, Amanda R ^a   Bartfai, Tamas ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloidosis; Dementia; Protein interaction; Protein misfolding

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; PREALBUMIN; ALBUMIN RECEPTOR; AMYLOID BETA PROTEIN; TRANSTHYRETIN RECEPTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC ANALYSIS; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; ANIMAL; ANIMAL BEHAVIOR; BIOCHEMISTRY; DISEASE MODEL; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; TRANSGENIC MOUSE;

MURINAE; MUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BEHAVIOR, ANIMAL; BIOCHEMISTRY; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; PREALBUMIN; RECEPTORS, ALBUMIN;

EID: 40649096849     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0712197105     Document Type: Article

References (31)

1. Schwarzman AL, et al. (1994) Transthyretin sequesters amyloid β protein and prevents amyloid formation. Proc Natl Acad Sci USA 91:8368-8372.
2. Schwarzman AL, Goldgaber D (1996) in The Nature and Origin of Amyloid Fibrils, eds Bock GR, Goode JA (Wiley, New York), pp 146-164.
3. Schwarzman AL, et al. (2004) Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants. Amyloid 11:1-9.
4. Link CD (1995) Expression of human β-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci USA 92:9368-9372.
5. Stein TD, Johnson JA (2002) Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J Neurosci 22:7380-7388.
6. Sturchler-Pierrat C, et al. (1997)Twoamyloid precursor protein transgenicmousemodels with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94:13287-13292.
7. Teng MH, et al. (2001) Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: A possible model for senile systemic amyloidosis. Lab Invest 81:385-396.
8. Episkopou V, et al. (1993) Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci USA 90:2375-2379.
9. Prut L, et al. (2007) Aged APP23 mice show a delay in switching to the use of a strategy in the Barnes maze. Behav Brain Res 179:107-110.
10. Levites Y, et al. (2006) Anti-Aβ42- and anti-Aβ40- specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J Clin Invest 116:193-201.
11. Crawley JN (2003) Behavioral phenotyping of rodents. Comp Med 53:140-146.
12. McLay RN, Freeman SM, Zadina JE (1998) Chronic corticosterone impairs memory performance in the Barnes maze. Physiol Behav 63:933-937.
13. Choi SH, et al. (2007) Accelerated Aβ deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin). J Neurosci 27:7006-7010.
14. Sousa JC, et al. (2007) Transthyretin influences spatial reference memory. Neurobiol Learn Mem 88:381-385.
15. Liu L, Murphy RM (2006) Kinetics of inhibition of β-Amyloid aggregation by transthyretin. Biochemistry 45:15702-15709.
16. Carro E, Trejo JL, Gonez-Isla T, LeRoith D, Torres-Aleman I (2002) Serum insulin-like growth factor I regulates brain amyloid-β levels. Nat Med 8:1390-1397.
17. Reixach N, et al. (2008) Human-murine transthyretin heterotetramers are kinetically stable and nonamyloidogenic: A lesson in the generation of transgenic models of diseases involving oligomeric proteins. J Biol Chem, 283:2098-2107.
18. Shirahama T, et al. (1982) Senile cerebral amyloid: Prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion. Am J Pathol 107:41-50.
19. Stein TD, et al. (2004) Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPsw mice resulting in Tau phosphorylation and loss of hippocampal neurons: Support for the amyloid hypothesis. J Neurosci 24:7707-7717.
20. Schreiber G (2002) The evolution of transthyretin synthesis in the choroid plexus. Clin Chem Lab Med 40:1200-1210.
21. Sousa JC, Cardoso I, Marques F, Saraiva MJ, Palha JA (2006) Transthyretin and Alzheimer's disease: Where in the brain? Neurobiol Aging 28:713-718.
22. Lein ES, et al. (2007) Genomewide atlas of gene expression in the adult mouse brain. Nature 445:168-176.
23. Zapala MA, et al. (2005) Adult mouse brain gene expression patterns bear an embryologic imprint. Proc Natl Acad Sci USA 102:10357-10362.
24. Sousa JC, et al. (2004) Transthyretin is involved in depression-like behavior and exploratory activity. J Neurochem 88:1052-1058.
25. Brouillette J, Quirion R (2007) Transthyretin: A key gene involved in the maintenance of memory capacities during aging. Neurobiol Aging, 10.1016/j.neurobiolaging.2007.04.007.
26. Goodman AB (2006) Retinoid receptors, transporters, and metabolizers as therapeutic targets in late-onset Alzheimer disease. J Cell Physiol 209:598-603.
27. Palha JA, et al. (1994) Thyroid hormone metabolism in a transthyretin-null mouse strain. J Biol Chem 269:33135-33139.
28. Yan C, Costa RH, Darnell JE, Jr, Chen JD, Van Dyke TA (1990) Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J 9:869-878.
29. Griffin WS, et al. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86:7611-7615.
30. Reixach N, Deechongkit S, Jiang X, Kelly JW, Buxbaum JN (2004) Tissue damage in the amyloidoses: Transthyretin monomers and non-native oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci USA 101:2817-2822.
31. Teplow DB (2006) Preparation of amyloid β-protein for structural and functional studies. Methods Enzymol 413:20-33.